skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

​Go behind the headlines

From licensing, to clinical trials, to competitor activity – you’ll stay up to date on news worldwide thanks to our global team of 60+ journalists. We go beyond headlines too, with access to key decision-makers and best-in-class proprietary data.

How it works

You’ll get business-critical market and company intelligence from our network of analysts, journalists and key opinion leaders. They cover companies from biotech start-ups to multinational giants such as Pfizer, Sanofi and Shire, and fields including cancer, cardiovascular, diabetes, dermatology, influenza and oncology.

How Scrip can help

Understand what’s behind the headlines – we focus on the strategic implications of global pharma news so you can see what developments mean for your business.

What's included

Follow market developments

Follow market developments

Scrips global team of journalists span key markets around the clock

Go beyond headlines

Go beyond the news

Get exclusive access to accurate data, timely insights and trusted analysis that delivers to gain competitive advantage




Hear from newsmakers

Hear from news makers

Access interviews with leading decision makers, industry experts and thought leaders, across the industry.


ask the analyst pharma intelligence

Ask the expert

Put your questions about any of our news stories, data and analysis to our expert journalists and analysts.


Pharma Intelligence: latest

Meet the team


Sten Stovall

Reporter-Journalist, Senior Editor, Pharma Insights
Sten Stovall

Sten specializes in

  • Policy & Regulation

+41 year(s) experience


John Hodgson

Editor, Executive Editor
John Hodgson

John specializes in

  • Policy & Regulation

+35 year(s) experience


Ian Schofield

Editor, Executive Editor, Pharma Insights
Ian Schofield

Ian specializes in

  • Policy & Regulation
  • Clinical Trials

+32 year(s) experience

How we've helped other businesses

"Scrip helps me to stay current with pharmaceutical news on a world-wide basis."

​Wendy Johnson ​CEO, Aires Pharmaceuticals, USA

"RxScorecard™ provides a comprehensive, multi-pronged rubric assisting us in decision-making as we begin to move from a volume to value drug evaluation methodology."

​Chronis H. Manolis, RPh ​Vice President, Pharmacy UPMC Health Plan

"RxScorecard™ lets a biopharma company anticipate the most important factors impacting the clinical & economic value of pipeline and marketed drugs -- and then helps identify the necessary changes to the clinical development and commercial program to maximize that value for all stakeholders, especially including payers. It's a required, straightforward, objective strategic tool that allows us to quickly and effectively adapt to a rapidly changing and much more challenging market access environment."

​Ammar Qadan ​Global Value/Market Access Lead Oncology Portfolio & Global Commercial Lead Oncology Biomarkers Halozyme Therapeutics, Inc.

Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907

Or email us your inquiry, so we can provide you the best possible customer service:

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: